Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Rizavi (Uxbridge, United Kingdom), T. Bandara (Uxbridge, United Kingdom), J. Morjaria (Uxbridge, United Kingdom). Is EBUS sampling adequate for molecular testing in patients with advanced NSCLC?. 3466

Member's Comments

No comment yet.

Related content which might interest you: Challenges in molecular testing in lung cancer patients with advanced disease Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007 Eminence or evidence based ? – personalised diagnostic-therapeutic sequences in a molecular altered advanced NSCLC patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017 Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800602; 10.1183/13993003.00602-2018 Year: 2018 Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800844; 10.1183/13993003.00844-2018 Year: 2018 Does routine use of EBUS-TBNA and EUS-FNA improve the accuracy of staging of non small cell lung cancer patients – A national tumor registry based study Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 How do cytology samples compare with histology specimens when used for EGFR testing in patients with NSCLC? Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012 Can molecular markers (EGFR, ERCC1) serve as screening parameters for adjuvant chemotherapy decision in early staged non-small cell lung cancer patients? Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001 A comparison of PET-CT and complete endosonographic nodal staging with use of 25 gauge needles in small nodes in NSCLC patients Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope Year: 2018 EBUS combined with EUS-B for a complete endoscopic staging of lung cancer Source: Virtual Congress 2021 – Interventional pulmonology Year: 2021 Modern profiling of advanced lung cancer at the primary diagnosis and during therapy Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 A diagnostic accuracy of surepath cytology in patients with lung cancer of central type on bronchoscopy Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020